Bureau Veritas Shares Fall 2.65% Despite Goldman Sachs' €40 Target
Bureau Veritas shares significantly declined this Tuesday, March 3, dropping 2.65% to €28.70 by midday, after closing at €29.48 the previous day. This downturn occurred in a session marked by a generalized retreat in European stock markets amid geopolitical tensions in the Middle East. However, the stock still maintains a 4.67% gain over the past seven days.
Goldman Sachs Updates Its Recommendation
On March 2, American bank Goldman Sachs updated its recommendation on Bureau Veritas, raising its price target from €39.50 to €40.00 while maintaining a buy rating. Given the current price of €28.70, this target implies a potential revaluation of about 39%. This upward revision reflects the institution’s confidence in the prospects of the specialist in inspection, certification, and laboratory testing services. Bureau Veritas is scheduled to publish its first-quarter results on April 22, which will assess the group's business momentum at the start of fiscal year 2026. The annual general meeting of shareholders is scheduled for May 19.
Technical Retracement to Upper Bollinger Band
Today's decline brings the stock back to its upper Bollinger band, set at €29.43, after briefly surpassing it in the previous session. This movement is seen as a classic technical retracement in a context where European markets are losing between 1 and 3%, influenced by military operations in Iran and a surge in energy prices. From a technical perspective, Bureau Veritas' stock still trades above its 50-day and 200-day moving averages, located at €27.46 and €27.55 respectively, indicating an underlying bullish trend. The RSI stands at 64, a level that does not indicate an overbought situation, allowing room for movement in either direction. The most relevant support is at €26.88, about 6.3% below the current price. Over three months, the stock still shows an 8.47% increase, signaling a positive dynamic preceding this session's correction.
